-
1.
公开(公告)号:US20100261707A9
公开(公告)日:2010-10-14
申请号:US12187115
申请日:2008-08-06
申请人: Gerard GRIFFIOEN , Kristel Marie Edith COUPET , Hein Roger DUHAMEL , Stefaan WERA , Ellen GOMME , Nele VAN DAMME , Ingrid VAN DER AUWERA , Marleen LOX , Tom VAN DOOREN , Tine DECRUY
发明人: Gerard GRIFFIOEN , Kristel Marie Edith COUPET , Hein Roger DUHAMEL , Stefaan WERA , Ellen GOMME , Nele VAN DAMME , Ingrid VAN DER AUWERA , Marleen LOX , Tom VAN DOOREN , Tine DECRUY
IPC分类号: A61K31/55 , A61K31/497 , A61P25/00
CPC分类号: A61K31/497 , A61K31/55
摘要: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
摘要翻译: 本发明提供特异性取代的1,2,4-噻二唑衍生物,用于治疗α-突触核蛋白病如帕金森病,弥漫性路易体病,创伤性脑损伤,肌萎缩性侧索硬化,尼曼 - 皮克病,哈勒沃尔登 - 斯帕茨综合征 ,唐氏综合征,神经性营养不良,多系统萎缩和阿尔茨海默病。 本发明还提供了制备这种取代的1,2,4-噻二唑衍生物的各种方法。
-
2.
公开(公告)号:US20090054410A1
公开(公告)日:2009-02-26
申请号:US12187115
申请日:2008-08-06
申请人: Gerard GRIFFIOEN , Kristel Marie Edith COUPET , Hein Roger DUHAMEL , Stefaan WERA , Ellen GOMME , Nele VAN DAMME , Ingrid VAN DER AUWERA , Marleen LOX , Tom VAN DOOREN , Tine DECRUY
发明人: Gerard GRIFFIOEN , Kristel Marie Edith COUPET , Hein Roger DUHAMEL , Stefaan WERA , Ellen GOMME , Nele VAN DAMME , Ingrid VAN DER AUWERA , Marleen LOX , Tom VAN DOOREN , Tine DECRUY
IPC分类号: A61K31/55 , A61K31/497 , A61P25/00
CPC分类号: A61K31/497 , A61K31/55
摘要: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
摘要翻译: 本发明提供了特异性取代的1,2,4-噻二唑衍生物,用于治疗α-突触核蛋白病如帕金森病,弥漫性路易体病,创伤性脑损伤,肌萎缩性侧索硬化,尼曼 - 皮克病,哈勒沃登 - 斯皮茨综合征 ,唐氏综合征,神经性营养不良,多系统萎缩和阿尔茨海默病。 本发明还提供了制备这种取代的1,2,4-噻二唑衍生物的各种方法。
-
3.
公开(公告)号:US08541406B2
公开(公告)日:2013-09-24
申请号:US12187115
申请日:2008-08-06
申请人: Gerard Griffioen , Kristel Marie Edith Coupet , Hein Roger Duhamel , Stefaan Wera , Ellen Gommé , Nele Van Damme , Ingrid Van Der Auwera , Marleen Lox , Tom Van Dooren , Tine Decruy
发明人: Gerard Griffioen , Kristel Marie Edith Coupet , Hein Roger Duhamel , Stefaan Wera , Ellen Gommé , Nele Van Damme , Ingrid Van Der Auwera , Marleen Lox , Tom Van Dooren , Tine Decruy
IPC分类号: A61K31/55 , C07D241/02
CPC分类号: A61K31/497 , A61K31/55
摘要: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
摘要翻译: 本发明提供了特异性取代的1,2,4-噻二唑衍生物,用于治疗α-突触核蛋白病如帕金森病,弥漫性路易体病,创伤性脑损伤,肌萎缩性侧索硬化,尼曼 - 皮克病,哈勒沃登 - 斯皮茨综合征 ,唐氏综合征,神经性营养不良,多系统萎缩和阿尔茨海默病。 本发明还提供了制备这种取代的1,2,4-噻二唑衍生物的各种方法。
-
公开(公告)号:US20090233911A2
公开(公告)日:2009-09-17
申请号:US12187115
申请日:2008-08-06
申请人: Gerard GRIFFIOEN , Kristel Marie Edith COUPET , Hein Roger DUHAMEL , Stefaan WERA , Ellen GOMMÉ , Nele VAN DAMME , Ingrid VAN DER AUWERA , Marleen LOX , Tom VAN DOOREN , Tine DECRUY
发明人: Gerard GRIFFIOEN , Kristel Marie Edith COUPET , Hein Roger DUHAMEL , Stefaan WERA , Ellen GOMMÉ , Nele VAN DAMME , Ingrid VAN DER AUWERA , Marleen LOX , Tom VAN DOOREN , Tine DECRUY
IPC分类号: A61K31/55 , A61K31/497 , A61P25/00
CPC分类号: A61K31/497 , A61K31/55
摘要: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
-
-
-